Ctxr sec filings

WebApr 6, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-018307 Submitted to the SEC: Wed Apr 06 2024 8:11:08 AM EST Accepted by the SEC: Wed Apr 06 2024 Period: Wednesday, April 6, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … WebMay 14, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Tuesday, March 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu May 14 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

Citius Pharmaceuticals - CTXR News Today - MarketBeat

WebFeb 8, 2024 · NASDAQ CTXR opened at $1.42 on Wednesday. Citius Pharmaceuticals, Inc. has a 12 month low of $0.77 and a 12 month high of $2.01. The firm has a market capitalization of $207.62 million, a PE ratio of -6.45 and a beta of 1.41. The company's 50 day simple moving average is $1.11 and its 200 day simple moving average is $1.13. WebNov 15, 2024 · Contact Us. Citius Pharmaceuticals, Inc. 11 Commerce Drive, First Floor Cranford, NJ 07016 908-967-6677 [email protected]. follow us on twitter cts behavioral health urgent care https://3princesses1frog.com

Citius Pharmaceuticals, Inc. (CTXR) 10K Annual Reports & 10Q SEC …

WebApr 3, 2024 · ctxr The Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 … WebSEC Filings. All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. … WebDec 22, 2024 · SEC Filings Citius Pharmaceuticals, Inc. (CTXR) 8-K Material Event Thu Dec 22 2024 Earnings Press Release 8-K Corporate News Citius Pharmaceuticals, Inc. … earthwise water technologies inc

Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly …

Category:Citius Pharmaceuticals, Inc. - Investors - Stock Information

Tags:Ctxr sec filings

Ctxr sec filings

Citius Pharmaceuticals, Inc. (CTXR) - Yahoo!

WebApr 6, 2024 · SEC Filings Short Interest Social Media Get Citius Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CTXR and its competitors with MarketBeat's FREE daily newsletter. CTXR Media Mentions By Week CTXR Media Sentiment CTXR News Sentiment 0.40 0.51 Average Medical News … WebCitius Pharmaceuticals Inc (NASDAQ:CTXR) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position …

Ctxr sec filings

Did you know?

Webctxrex1012.htm exhibit 10.12 placement agent's unit warrants neither these securities nor the securities issuable upon exercise of these securities have been registered with the … WebThese reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Citius Pharmaceuticals Inc

WebJan 15, 2013 · Ticker: CTXR CIK: 1506251 Form Type: 10-K Annual Report Accession Number: 0001185185-13-000090 Submitted to the SEC: Tue Jan 15 2013 1:09:25 PM EST Accepted by the SEC: Tue Jan 15 2013 Period: Sunday, September 30, 2012 Industry: Pharmaceutical Preparations External Resources: Stock Quote Social Media Bookmark … WebApr 3, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-23-026265 Submitted to the SEC: Mon Apr 03 2024 4:05:20 PM …

WebApr 6, 2024 · Citius Pharmaceuticals, Inc. SEC Filing - Quarterly Report (10-Q) February 10, 2024 SEC FilingsFri, Feb. 10 Citius Pharmaceuticals, Inc. SEC Filing - Proxy … WebFeb 10, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 8-K Material Event for the period ending Friday, February 10, 2024

WebFeb 11, 2024 · Citius Pharmaceuticals, Inc. (CTXR) SEC Filing 10-Q Quarterly report for the period ending Thursday, December 31, 2024. Home. SEC Filings. Citius Pharmaceuticals, Inc. (CTXR) 10-Q Quarterly Report Thu Feb 11 2024; SEC Filings. CTXR Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades.

WebApr 10, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTXR shares currently have a short interest ratio of 13.0. Learn More on Citius Pharmaceuticals's short interest ratio. earthwise witch hazelWebCitius Pharmaceuticals Inc. SEC filings breakout by MarketWatch. View the CTXR U.S. Securities and Exchange Commission reporting information. cts® bd1 stainless steelWebSep 28, 2024 · Ticker: CTXR CIK: 1506251 Form Type: 8-K Corporate News Accession Number: 0001213900-22-059746 Submitted to the SEC: Wed Sep 28 2024 4:05:14 PM EST Accepted by the SEC: Wed Sep 28 2024 Period: Wednesday, September 28, 2024 Industry: Pharmaceutical Preparations Events: Financial Exhibit; Other Events; External … cts beaconWebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. earthwise trimmer replacement spool capWebCitius Pharmaceuticals, Inc. Daily – Vickers Top Buyers & Sellers for 04/08/2024 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider ... earthwise trimmer spool capWebJun 22, 2024 · Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Submission of Matters to a Vote of Security Holders Item 3.03 – Material Modification to Rights of … cts bellinghamWebCommon stock, $0.001 par value CTXR The Nasdaq Capital Market  Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ cts bergamo